Monocyte activation in patients with Wegener's granulomatosis

Annals of the Rheumatic Diseases

Volumn 58, Issue 4, 1999, Pages 237-245

  Muller Kobold, Anneke C ^a   Kallenberg, Cees G M ^a   Cohen Tervaert, Jan Willem ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; C REACTIVE PROTEIN; CD11B ANTIGEN; CD63 ANTIGEN; CD64 ANTIGEN; ELASTASE; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOBLASTIN; MYELOPEROXIDASE; NEOPTERIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; LEUKOCYTE ACTIVATION; MONOCYTE; PRIORITY JOURNAL; SEROLOGY; WEGENER GRANULOMATOSIS;

EID: 0032934053     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.58.4.237     Document Type: Article

References (45)

1. 1 Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994;46:1-15.
2. 2 Cohen Tervaert JW, Huitema MG, Hene RJ, Sluiter WJ, The TH, van der Hem GK, et al. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990;336:709-11.
3. 3 Falk RJ, Terrell RS, Charles LA, Jennette JC. Antineutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990;87:4115-19.
4. 4 Charles LA, Caldas ML, Falk RJ, Terrell RS, Jennette JC. Antibodies against granule proteins activate neutrophils in vitro. J Leukoc Biol 1991;50:539-46.
5. 5 Savage CO, Pottinger BE, Gaskin G, Pusey CD, Pearson JD. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol 1992;141:335-42.
6. 6 Mayet WJ, Meyer zum Buschenfelde KH. Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells. Clin Exp Immunol 1993;94:440-6.
7. 7 Ewert BH, Becher ME, Jennette JC, Falk RJ. Antimycloperoxidase antibodies induce neutrophil adherence to cultured human endothelial cells. Ren Fail 1995;17:125-33.
8. 8 Csernok E, Ernst M, Schmitt W, Bainton DF, Gross WL. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 1994;95:244-50.
9. 9 Porges AJ, Redecha PB, Kimberly WT, Csernok E, Gross WL, Kimberly RP. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J Immunol 1994;153;1271-80.
10. 10 Mulder AH, Heeringa P, Brouwer E, Limburg PC, Kallenberg CGM. Activation of granulocytes by anti-neutrophil cytoplasmic anybodies (ANCA): a Fc gamma RII-dependent process. Clin Exp Immunol 1994;98;270-8.
11. 11 Rastaldi MP, Ferrario F, Tunesi S, Yang L, D'Amico G. Intraglomerular and interstitial leukocyte infiltration, adhesion molecules, and interleukin-1a expression in 15 cases of antineutrophil cytoplasmic autoantibody-associated renal vasculitis. Am J Kidney Dis 1996;27:48-57.
12. 12 Pike PC. The role of the monocyte and macrophage in the pathogenisis of vasculitis. In: LeRoy EC, ed. Systemic vasculitis. The biological basis. New York: Marcel Dekker, 1992:129-47.
13. 13 Ralston DR, Marsh CB, Lowe MP, Wewers MD. Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase 3, alpha1-antitrypsin, and Fcgamma receptors. J Clin Invest 1997;100:1416-24.
14. 14 Casselman BL, Kilgore KS, Miller BF, Warren JS. Antibodies to neutrophil cytoplasmic antigens induce monocyte chemoattractant protein-1 secretion from human monocytes. J Lab Clin Med 1995;126:495-502.
15. 15 Riecken B, Gulfleisch J, Schlesier M, Peter HH. Impaired granulocyte oxidative burst and decreased expression of leucocyte adhesion molecule-1 (LAM-1) in patients with Wegener's granulomatosis. Clin Exp Immunol 1994;96: 43-7.
16. 16 Haller H, Eichhorn J, Pieper K, Goebel U, Luft FC. Circulating leukocyte integrin expression in Wegener's granulomatosis. J Am Soc Nephrol 1996;7:40-8.
17. 17 Ziegler EJ, Fisher CJ Jr, Sprung CL, Straube RC, Sadoff JC, Foulke GE, et al. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomixed, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med 1991;324:429-36.
18. 18 Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98:76-85.
19. 19 Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification, of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
20. 20 Stegeman CA, Cohen Tervaert JW, de Jong PE, Kallenberg CGM. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 1996;335:16-20.
21. 21 Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994;87;671-8.
22. 22 Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage CO, et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 1997;40;371-80.
23. 23 Cohen Tervaert JW, Mulder L, Stegeman C, Elema J, Huitema M, The II, et al. Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders. Ann Rheum Dis 1993;52: 115-20.
24. 24 Cohen Tervaert JW, Goldschmeding R, Elema JD, van der Giessen M, Huitema MG, van der Hem GK, et al. Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 1990;37:799-806.
25. 25 Mulder AH, Brockroclofs J, Horst G, Limburg PC, Nelis GF, Kallenberg CGM. Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates. Clin Exp Immunol 1994;95: 490-7.
26. 26 Fuchs D, Weiss G, Reibnegger G, Wachter H. The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases, Crit Rev Clin Lab Sciences 1992;29;307-41.
27. 27 Samsonov MY, Tilz GP, Egorova O, Reibnegger G, Nassonov EL, Nassonova VA, et al. Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus. Lupus 1995;4:29-32.
28. 28 Haupt W, Hohenberger W, Klein P, Christou NV. Detection of neopterin, interleukin 6 and acute phase proteins as parameters of potential monocyte activation in preoperative patients. Infection 1995;23:263-6.
29. 29 Horneff G, Sack U, Kalden JR, Emmerich F, Burmester GR. Reduction of monocyte-macrophage activation markers upon anti-CD4 treatment. Decreased levels of IL-1, IL-6, neopterin and soluble CD14 in patients with rheumatoid arthritis. Clin Exp Immunol 1993;91:207-13.
30. 30 Helle M, Boeye L, Groot Ed, Vis Ad, Aarden L. Sensitive Elisa for interleukin-6: Detection of IL-6 in biological fluids: synovial fluids and sera. J Immunol Methods 1991; 138:47-56.
31. 31 Kuijpers TW, Tool AT, van der Schoot CE, Ginsel LA, Onderwater JJ, Roos D, et al. Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood 1991;78: 1105-11.
32. 32 Muller Kobold AC, Kallenberg CGM, Cohen Tervaert JW. Leukocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis, Br J Rheumatol 1998;37:901-7.
33. 33 Liote F, Boval-Boizard B, Weill D, Kuntz D, Wautier JT. Blood monocyte activation in rheumatoid arthritis: increased monocyte adhesiveness, integrin expression, and cytokine release. Clin Exp Immunol 1996;106:13-9.
34. 34 Sladek TL, Jacobbergor JW. Flow cytometric titration of retroviral expression vectors: comparison of methods for analysis of immunofluorescence histograms derived from cells expressing low antigen levels. Cytometry 1993;14:23-31.
35. 35 Metzclaar MJ, Wijngaard PL, Peters PJ, Sixma JJ, Nieuwenhuis HK, Clevers HC, CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. J Biol Chem 1991;266:3239-45.
36. 36 Valerius T, Repp R, de Wit TP, Berthold S, Platzer E, Kalden JR, et al. Involvement of the high-affinity receptor for IgG (Fc gamma RI; CD64) in enhanced tumor cell cytotoxicity of neutrophils during granulocyte colony-stimulating factor therapy. Blood 1993;82:931-9.
37. 37 Aulitzky WE, Tilg H, Niederwieser D, Riccabona G, Obendorf L, Margreiter R, et al. Comparison of serum neopterin levels and urinary excretion in renal allograft recipients. Clin Nephrology 1988;29:248-52.
38. 38 Nassonov E, Samsonov M, Beketova T, Semenkova L, Wachter H, Fuchs D. Serum neopterin concentrations in Wegener's granulomatosis correlate with vasculitis activity. Clin Exp Rheumatol 1995;13:353-6.
39. 39 Wayner EA, Garcia Pardo A, Humphries MJ, McDonald JA, Carter WG. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J Cell Biol 1989;109:1321-30.
40. 40 Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-34.
41. 41 Stegeman CA, Cohen Tervaert JW, Huitema MG, de Jong PE, Kallenberg CGM. Serum levels of soluble adhesion molecules intercellular adhesion molecule 1, vascular adhesion molecule 1, and E-selectin in patients with Wegener's granulomatosis. Arthritis Rheum 1994;37:1228-35.
42. 42 Pinching AJ, Rees AJ, Pussell BA, Lockwood CM, Mitchison RS, Peters DK. Relapses in Wegener's granulomatosis: the role of infection. BMJ 1980;281: 836-8.
43. 43 Falk RJ, Hogan S, Carey TS, Jennette JC. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. Ann Intern Med 1990; 113:656-63.
44. 44 Stegeman CA, Cohen Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CGM. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 1994;120:12-17.
45. 45 Cohen Tervaert JW, Kallenberg CGM. Cell adhesion molecules in vasculitis. Curr Opin Rheumatol 1997;9:16-25.